Passage BIO, Inc. (PASG) stock
PASGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$4.22+0.09 (+2.18%)
Close on Nov 17, 2026Market cap $13.58MP/E –Yield –
Passage BIO price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Passage BIO's price to book ratio was 2.9× on Nov 11, 2026, against 0.9× a year earlier. Over the last 5 years it ranged from 0.2× to 3.2×, with a median of 0.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.9× | +1.7 |
| 2025 | Dec 31, 2025 | 1.2× | +0.7 |
| 2024 | Dec 31, 2024 | 0.5× | +0.0 |
| 2023 | Dec 29, 2023 | 0.4× | +0.1 |
| 2022 | Dec 30, 2022 | 0.3× | −0.6 |
| 2021 | Dec 31, 2021 | 1.0× | −2.6 |
| 2020 | Dec 31, 2020 | 3.5× | – |
See a number that looks wrong?